NCT04065932 A Study to Determine the Pharmacokinetic Profile of BMS-986165 Tablets Status COMPLETED Phase PHASE1
NCT04057365 Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC) Status TERMINATED Phase PHASE2
NCT04055506 A Study to Investigate the Effects of Cytochrome P450 1A2 Induction by Ritonavir on BMS-986165 Drug Levels and Effects in Healthy Participants Status COMPLETED Phase PHASE1
NCT04050085 SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT04045639 A Study to Assess the Effectiveness of an Atrial Fibrillation (AF) Risk Prediction Algorithm and Diagnostic Test in Identifying Patients With AF. Status COMPLETED Phase N/A
NCT04044430 Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer Status TERMINATED Phase PHASE1
NCT04043975 A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan Status COMPLETED Phase N/A
NCT04042116 A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor Status SUSPENDED Phase PHASE1/PHASE2
NCT04039607 A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04039373 Effects of BMS-986256 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate Mofetil Status COMPLETED Phase PHASE1
NCT04036435 Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04026412 A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery Status COMPLETED Phase PHASE3
NCT04025879 A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04022980 Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma Status COMPLETED Phase PHASE1
NCT04021108 Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L) Status ACTIVE_NOT_RECRUITING Phase PHASE2